The World Health Organisation renewed the Barcelona Institute for Global Health (ISGlobal) designation as a WHO Collaborating Centre for Malaria Control, Elimination and Eradication in 2017.
The designation falls within WHO's Collaborating Centres programme, designed to harness the expertise and capacities of leading research institutions to support its own activities.
As a WHO Collaborating Centre, ISGlobal will:
- Support WHO policy-making and guidance on malaria elimination: ISGlobal will support WHO policy making on malaria elimination by ensuring knowledge transmission in the scientific and policy making evidence in key areas such as operational research that improves the use of drugs, insecticides, diagnostics and vaccines for malaria elimination and the identification of areas in need of policy guidance.
- Support the WHO Strategic Advisory Group (SAG) on Malaria Eradication: ISGlobal supports SAG through evidence reviews defined in collaboration with the Global Malaria Programme (GMP) and knowledge generation for the most effective strategies for malaria elimination.
- Develop and test new products, indications and strategies for malaria control and elimination that inform WHO policy and guidance: ISGlobal assesses the potential role of novel products for malaria elimination such as the impact of ivermectin and other tools as vector control tool for residual transmission.
- Conduct evidence reviews and analysis to support Evidence Review Groups (ERG), Technical Expert Groups or the development of new or updated programme guidance: ISGlobal produces new scientific evidence and rigorous analysis that informs the WHO guidelines for malaria elimination in unexplored or underexplored fields of knowledge.
- Support leadership and education with the creation of the Science of Eradication Course: The ISGlobal Malaria Elimination Initiative aims at advancing research, training and policy to create impact.